Skip to Main Content

Paper Details

Blood Biomarkers for Detection of Brain Injury in COVID-19 Patients.
J Neurotrauma
55
2021
BB proteins, BBs, Brain Injury, COVID-19, Central nervous system, Patients, SARS, SARS-, SARS-COV-2, SARS-COV-2 virus, SARS-CoV, SARS-CoV-2, brain, brain injury, cardiac arrest, coronavirus disease, epilepsy, human immunodeficiency virus, hypoxia, infectious diseases, neurological deficits, neurological disturbances, patient, patients, severe acute respiratory syndrome coronavirus 2, stroke, traumatic brain injury, tuberculous meningitis
Author NameAffiliation
Patrick M Kochanekand Clinical and Translational Science, Safar Center for Resuscitation Research, University of Pittsburgh School of Medicine, UPMC Children's Hospital of Pittsburgh
Alex B ValadkaVirginia Commonwealth University
Robert S B ClarkUniversity of Pittsburgh School of Medicine
Alicia K AuUniversity of Pittsburgh, UPMC Children's Hospital of Pittsburgh
Christopher M HorvatUniversity of Pittsburgh School of Medicine, UPMC Children's Hospital of Pittsburgh
Stephen R WisniewskiUniversity of Pittsburgh
Max WintermarkStanford University
Stacey L HouseWashington University School of Medicine
Rudolph E TanziGenetics and Aging Research Unit, Massachusetts General Hospital, McCance Center for Brain Health, MassGeneral Institute for Neurodegenerative Diseases, Harvard Medical School
  • 1 - 9

Datasets

Release 1.2